Filters
Unique and hitherto undescribed tumors of the skin subcutaneous soft tissues. (IZ2616)
9F - 9
- 1995 - 1996 •
- 0 tis. Kč •
- 0 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1995 - 1. 1. 1996
Uznané náklady
Podpora ze státního rozpočtu
Poskytovatel: Ministerstvo zdravotnictví
Assessment of Skin Phototypes Performance and Its Clinical Implication. (IZ1975)
9F - 9
- 1994 - 1996 •
- 305 tis. Kč •
- 420 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1994 - 1. 1. 1996
Uznané náklady
Podpora ze státního rozpočtu (138%)
Poskytovatel: Ministerstvo zdravotnictví
Recombined artificial skin for treatment of burns (ND5699)
The projekt aims to optimize the authorś original "artificial skin" technique based on a collagen -HA composite and polyurethan membrane, to upgrade it through seeding with fibroblasts and to conduct a randomized clinical study for its evaluation.......
FJ - Chirurgie včetně transplantologie
- 1999 - 2001 •
- 1 874 tis. Kč •
- 1 834 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1999 - 1. 1. 2001
Uznané náklady
Podpora ze státního rozpočtu (98%)
Poskytovatel: Ministerstvo zdravotnictví
Cell-mediated multilayered 4th generation biomimetic scaffold for single-step total skin substitute from laboratory to clinical application (NU22-08-00454)
Skin tissue engineering exploiting non-toxic resorbable biomaterials has been a major success in the last few decades. In the skin, one can find various cell populations that are arranged in a unique three-dimensional matrix, creating a complex of mi...
Transplantation
- 2022 - 2025 •
- 14 308 tis. Kč •
- 14 308 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2022 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Microbiota as a biomarker for prediction of mucocutaneous adverse effects of biologics used in inflammatory bowel disease (NV18-09-00493)
Biologics are powerful group of drugs used in treatment of many inflammatory diseases, including inflammatory bowel diseases (IBD). Their use is often limited by muco-cutaneous adverse events. Pathogenesis of these events is poorly understood, and pa...
Microbiology
- 2018 - 2022 •
- 10 316 tis. Kč •
- 10 262 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2018 - 31. 12. 2022
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
New approaches to infected wound healing using hydrogels from Gum Karaya natural resin modified with innovative components targeted at multidrug resistant bacterial strains (NU20-05-00166)
The increase in resistance of microorganisms is a current worldwide problem, not only in hospitalized patients, but also in patients treated on an outpatient basis. Therefore, it is necessary to look for innovative therapeutic alternatives that could...
Infectious Diseases
- 2020 - 2023 •
- 10 476 tis. Kč •
- 10 476 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2020 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Treatment of Infections Caused by Multidrug-Resistant Bacterial Strains by Novel Antibacterial Preparations Based on Cathelicidin Antimicrobial Peptides (NU22-05-00475)
The increase in antimicrobial resistance is a current worldwide problem not only for hospitalised patients but also in patients treated on an outpatients basis. Therefore it is necessary to find novel therapeutic alternatives that could reduce antibi...
Infectious Diseases
- 2022 - 2025 •
- 11 376 tis. Kč •
- 11 376 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2022 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Utilization of RT-QuIC assay for improvement of diagnostics of neurodegenerative diseases Prospective and retrospective studies (NU23-04-00173)
Many common neurodegenerative proteinopathies like Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies or prion diseases are related to deposition of specific pathological amyloid forming proteins within the brain tissue. At present, ...
Medical laboratory technology (including laboratory samples analysis; diagnostic technologies) (Biomaterials to be 2.9 [physical characteristics of living material as related to medical implants, devices, sensors])
- 2023 - 2026 •
- 13 085 tis. Kč •
- 13 085 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2023 - 31. 12. 2026
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Skin Barrier Lipidomics as a Noninvasive Method for Predicting Late Adverse Events in Childhood Cancer Survivors (NW24-08-00289)
Childhood cancer survivors are at risk of developing a number of late adverse effects that are difficult to predict and are likely related to premature aging. Based on the experience of our team of clinical oncologists, dermatologists and skin barrie...
Analytical chemistry
- 2024 - 2027 •
- 10 267 tis. Kč •
- 10 267 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2024 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Health risk of sub-chronic phytocannabinoids application (NW24-09-00244)
Preparations containing phytocannabinoids (PCBs) are very popular and are widely used orally, dermally or inhaled, mainly for their anti-inflammatory and analgesic effects. Most users consider non-psychotropic PCBs to be free of health risks. Commerc...
Dermatology and venereal diseases
- 2024 - 2027 •
- 12 574 tis. Kč •
- 12 574 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2024 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 10 out of 10